OMB Control No:
0920-0978
ICR Reference No:
202505-0920-009
Status:
Received in OIRA
Previous ICR Reference No:
202504-0920-028
Agency/Subagency:
HHS/CDC
Agency Tracking No:
0920-25-0122
Title:
[NCEZID] Emerging Infections Program
Type of Information Collection:
No material or nonsubstantive change to a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
Date Submitted to OIRA:
06/03/2025
Requested
Previously Approved
Expiration Date
09/30/2027
09/30/2027
Responses
88,158
88,158
Time Burden (Hours)
40,013
40,013
Cost Burden (Dollars)
0
0
Abstract:
The Emerging Infections Programs (EIP) is to 1) detect and monitor emerging pathogens, the diseases they cause, and the factors influencing their emergence, and respond to problems as they are identified, 2) integrate laboratory science and epidemiology to optimize public health practice, 3) strengthen infrastructure to support surveillance and research and to implement prevention and control programs, and to 4) ensure implementation of prevention strategies and communication of public health information about emerging diseases. Surveillance efforts of the core EIP activities generate reliable estimates of the incidence of certain infections and provide the foundation for a variety of epidemiologic studies.
This Non-Substantive Change Request is submitted to make minor modifications to approved instruments including revised formatting, rewording, new answer options, and the addition/subtraction of a limited number of questions. There is no anticipated change to the approved burden hours.
Authorizing Statute(s):
US Code:
42 USC 301
Name of Law: Public Health Service Act
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
89 FR 14501
02/27/2024
30-day Notice:
Federal Register Citation:
Citation Date:
89 FR 58736
07/19/2024
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
32
IC Title
Form No.
Form Name
(MuGSI) Healthcare-Associated Infections Community Interface (HAIC) Case Report
HAIC 400.1, HAIC 400.1, HAIC 400.1
2024 Multi-site Gram-Negative Surveillance Initiative (MuGSI) Healthcare-Associated Infections Community Interface (HAIC) Case Report_rev 2025
,
2025 Multi-site Gram-Negative Surveillance Initiative (MuGSI) Healthcare-Associated Infections Community Interface (HAIC) Case Report _rev 2025
,
HAIC.400.1 Multi-Site Gram-Negative Surveillance Initiative (MuGSI) Case Report Form - 2026
2019 ABCs H. Influenzae Neonatal Sepsis Expanded Surveillance Form
ABC.100.3
2019 ABC H. Influenzae Neonatal Sepsis Expanded Surveillance Form
2024 Active Bacterial Core Surveillance (ABCs) Case Report
ABC.100.1, ABC 100.1
2024 Active Bacterial Core Surveillance (ABCs) Case Report
,
2025 Active Bacterial Core Surveillance (ABCs) Case Report
ABCs Invasive Pneumococcal Disease in Children and Adults
ABC.100.2, ABC 100.2
ACTIVE BACTERIAL CORE SURVEILLANCE (ABCs) INVASIVE PNEUMOCOCCAL DISEASE IN CHILDREN (aged ≥2 months to <5 years) AND ADULTS (aged ≥65 years)
,
2025 ACTIVE BACTERIAL CORE SURVEILLANCE (ABCs) INVASIVE PNEUMOCOCCAL DISEASE IN CHILDREN (aged ≥2 months to <5 years) AND ADULTS (aged ≥65 years)
ABCs Severe GAS Infection: Supplemental Form
ABC.100.4
ABCs Severe GAS Infection: Supplemental Form
Active Bacterial Core Surveillance (ABCs) Neonatal Infection Expanded Tracking Form
ABC.100.5, ABC 100.5
ACTIVE BACTERIAL CORE SURVEILLANCE (ABCs) NEONATAL INFECTION EXPANDED TRACKING FORM
,
2025 ACTIVE BACTERIAL CORE SURVEILLANCE (ABCs) NEONATAL INFECTION EXPANDED TRACKING FORM
Annual Survey of Laboratory Testing Practices for C. difficile Infection
HAIC.400.8, HAIC 400.8, HAIC 400.8
Annual Survey of Laboratory Testing Practices for C. difficile Infection
,
Annual Survey of Laboratory Testing Practices for C. difficile Infection
,
HAIC.400.8 Annual Survey of Laboratory Testing Practices for C. difficile Infections - 2026
CANDIDEMIA 2024 CASE REPORT FORM
HAIC 400.11, HAIC 400.11
CANDIDEMIA 2024 CASE REPORT FORM_rev 2025
,
CANDIDEMIA 2025 CASE REPORT FORM_rev 2025
CDC's Healthcare-Associated Infections Community Interface (HAIC) Staphylococcus aureus 2024 Laboratory Survey
HAIC.400.5
CDC’s Healthcare-Associated Infections Community Interface (HAIC) Staphylococcus aureus 2024 Laboratory Survey
CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) SURVEILLANCE EMERGING INFECTIONS PROGRAM CASE REPORT
HAIC 400.7, HAIC 400.7, HAIC 400.7
2024 CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) SURVEILLANCE EMERGING INFECTIONS PROGRAM CASE REPORT_rev 2025
,
2025 CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) SURVEILLANCE EMERGING INFECTIONS PROGRAM CASE REPORT_ rev 2025
,
HAIC.400.7 CDI Case Report and Treatment Form - 2026
Community-Associated CP-CRE Interview
HAIC.400.2
Community-Associated CP-CRE Interview
Data Elements Transferred to CDC for the HAIC Death Ascertainment Project
HAIC.400.13
Data Elements Transferred to CDC for the HAIC Death Ascertainment Project
Emerging Infections Program C. difficile Surveillance Nursing Home Telephone Survey
HAIC.400.10
Emerging Infections Program C. difficile Surveillance Nursing Home Telephone Survey
FLUSURV-NET: CONSENT FORM FOR PATIENT/PROXY INTERVIEW (English/Spanish)
FSN.300.2
FLUSURV-NET: CONSENT FORM FOR PATIENT/PROXY INTERVIEW
FLUSURV-NET: PROVIDER PEDIATRIC VACCINATION HISTORY REQUEST LETTER/FORM
FSN.300.3
FLUSURV-NET: PROVIDER PEDIATRIC VACCINATION HISTORY REQUEST LETTER/FORM
FluSurv-NET Laboratory Survey 2023–2024 Season
FSN.300.4
FluSurv-NET Laboratory Survey 2023–2024 Season
FluSurv-Net Influenza Hospitalization Surveillance Network Case Report Form
FSN.300.1, FSN 300.1
Influenza Hospitalizatin Surveillance Network (FluSurv-NET) Case Report Form
,
2024-25 Influenza Hospitalization Surveillance Network (FluSurv-NET) Case Report Form
FoodNET Lab Survey Variable List 2024
FN.200.10
FoodNET Lab Survey Variable List, 2024
FoodNet Hemolytic Uremic Syndrome (HUS)
ABC 200.9
FoodNet CDC's FoodNet Hemolytic Uremic Syndrome (HUS) Surveillance Case Report Form_rev 2025
FoodNet Variable List, 2024_ (CYCLOSPORA)
FN200.2, FN.200.2, FN 200.2
FoodNet Variable List, 2024_ (CYCLOSPORA)
,
FoodNet Variable List, (Site-transmitted variables) - 2025
,
FN200.1-200.8_FoodNet Variable List_2026
FoodNet Variable List, 2024_ (LISTERIA MONOCTOGENES)
FN200.3, FN.200.3, FN 200.3
FoodNet Variable List, 2024_ (LISTERIA MONOCYTOGENES)
,
FoodNet Variable List, (Site-transmitted variables) - 2025
,
FN200.1-200.8_FoodNet Variable List_2026
FoodNet Variable List, 2024_ (SALMONELLA)
FN200.4, FN.200.4, FN 200.4
FoodNet Variable List, 2024_ (SALMONELLA)
,
FoodNet Variable List, (Site-transmitted variables) - 2025
,
FN200.1-200.8_FoodNet Variable List_2026
FoodNet Variable List, 2024_ (SHIGA TOXIN PRODUCING E.COLI)
FN200.5, FN.200.5, FN 200.5
FoodNet Variable List, 2024_ (SHIGA TOXIN PRODUCING E.COLI)
,
FoodNet Variable List, (Site-transmitted variables) - 2025
,
FN200.1-200.8_FoodNet Variable List_2026
FoodNet Variable List, 2024_ (SHIGELLA)
FN200.6, FN.200.6, FN 200.6
FoodNet Variable List, 2024_ (SHIGELLA)
,
FoodNet Variable List, (Site-transmitted variables) - 2025
,
FN200.1-200.8_FoodNet Variable List_2026
FoodNet Variable List, 2024_ (VIBRIO)
FN200.7, FN.200.7, FN 200.7
FoodNet Variable List, 2024_ (VIBRIO)
,
FoodNet Variable List, (Site-transmitted variables) - 2025
,
FN200.1-200.8_FoodNet Variable List_2026
FoodNet Variable List, 2024_ (YERSINIA)
FN200.8, FN.200.8, FN 200.8
FoodNet Variable List, 2024_ (YERSINIA)
,
FoodNet Variable List, (Site-transmitted variables) - 2025
,
FN200.1-200.8_FoodNet Variable List_2026
FoodNet Variable List, 2024_(CAMPYLOBACTER)
FN200.1, FN.200.1, FN 200.1
FoodNet Variable List, 2024_ (CAMPYLOBACTER)
,
FoodNet Variable List, (Site-transmitted variables) - 2025
,
FN200.1-200.8_FoodNet Variable List_2026
HAIC Invasive Staphylococcus aureus Supplemental Surveillance Officer Survey
HAIC.400.6, HAIC 400.6, HAIC 400.6
2023 HAIC Invasive Staphylococcus aureus Supplemental Surveillance Officer Survey
,
2024 HAIC Invasive Staphylococcus aureus Supplemental Surveillance Officer Survey
,
HAIC.400.6 HAIC Invasive Staphylococcus aureus Supplemental Surveillance Officer Survey - 2026
HAIC Multi-site Gram-negative Surveillance Initiative (MuGSI) Supplemental Surveillance Officer Survey
HAIC.400.3, HAIC 400.3
2024 HAIC Multi-site Gram-negative Surveillance Initiative (MuGSI) Supplemental Surveillance Officer Survey
,
HAIC.400.3–HAIC MuGSI Supplemental Surveillance Officer Survey - 2026
HAIC-Surveillance Officer's Survey
HAIC.400.9, HAIC 400.9, HAIC 400.9
HAIC Surveillance Officer’s Survey
,
HAIC Surveillance Officer’s Survey
,
HAIC.400.9 CDI Annual Surveillance Officers Survey - 2026
HAIC_LABORATORY TESTING PRACTICES FOR CANDIDEMIA QUESTIONNAIRE
HAIC.400.12, HAIC 400.12
2024 LABORATORY TESTING PRACTICES FOR CANDIDEMIA QUESTIONNAIRE
,
2025 LABORATORY TESTING PRACTICES FOR CANDIDEMIA QUESTIONNAIRE
Invasive Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report
HAIC 400.4, HAIC 400.4, HAIC 400.4, HAIC 400.4, HAIC 400.4, HAIC 400.4, HAIC 400.4
2024 Invasive Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report_rev 2025
,
2025 Invasive Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report_rev 2025
,
2022 Invasive Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report _rev 2025
,
2023 Invasive Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report _rev 2025
,
2022 Invasive Methicillin-Sensitive Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report _rev 2025
,
2023 Invasive Methicillin-Sensitive Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report _rev 2025
,
HAIC.400.4 Invasive Staphylococcus aureus HAIC Case Report - 2026
ICR Summary of Burden
Total Request
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
88,158
88,158
0
0
0
0
Annual Time Burden (Hours)
40,013
40,013
0
0
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
No
Burden Increase Due to:
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
Annual Cost to Federal Government:
$41,699,051
Does this IC contain surveys, censuses, or employ statistical methods?
Yes
Part B of Supporting Statement
Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
Yes
Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3) )? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
No
Agency Contact:
Jeffrey Zirger 404 639-7118 wtj5@cdc.gov